This new approach, based on natural selection, dramatically improves the reliability of large language models for practical ...

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

AI creatives with access to Google’s Veo 2 text-to-video tool say it’s another “leap forward” for video generation Veo 2 ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year.

The order, signed in October 2023, required companies building powerful AI systems to share their safety test results with the federal government and come up with ways to limit their models’ biases ...

The company fulfilled requests from Israel’s military for more access to AI tools as it sought to compete with Amazon, ...

This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of ...

The researchers subjected nine large language models to a series of twisted games to see how they would respond to the idea of 'pain' and 'pleasure' ...

Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...

Google DeepMind AI for Science Scholarships are now available, offering African students the opportunity to pursue ...

Demis Hassabis is the CEO of Google DeepMind. Demis thinks new agent type systems will be able to perform additional tree of knowledge search to achieve ...